E.I.D. - Parry (India) Ltd.

EIDPARRY

₹832.4

-0.95% (-7.95)

Market Cap

₹14,815 Cr.

P/E

18.24

About

E.I.D. - Parry (India) Limited, a top player in the Indian sugar industry, also excels in Bio-Pesticides and Nutraceuticals. With a strong presence in South India, it focuses on process efficiencies, … Read more

E.I.D. - Parry (India) Limited, a top player in the Indian sugar industry, also excels in Bio-… Read more

Low

593

52W Range

High

997

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

12 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Margin Stability

Margins of the company are volatile

Market Share

10 %

(as of Mar 18)

Source/Historic

Astaxanthin - Market Share

30 %

(as of Mar 18)

Source/Historic

Organic Spirulina - Market Share

15.80 %

(as of Mar 20)

Source/Historic

Phosphatic Fertilizers - Market Share

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Nutraceuticals

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Asset Break-Up - Segment Wise

Asset Break-Up

Operational Metrics

Sugar Recovery (%)
Source
Realization / Litre - Distillery (Rs/L)
Source
Realization / Unit - Cogeneration (Rs/Unit)
Source
Realization / Kg - Sugar (Rs/Kg)
Source
Capacity Utilization - Cogeneration (%)
Source
Capacity Utilization - Sugar (%)
Source
Sugarcane Crushed - Daily (TPD)
Source
Distillery Sold Volume - Quarterly (Cr Lts)
Source
Ethanol Sold Volume - Quarterly (Cr Lts)
Source

Peer Comparison

Brands

Parrys

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Customers

Cadbury
Pepsico

FAQs on E.I.D. - Parry (India) Ltd. Business

What does E.I.D. Parry (I) do?

E.I.D. - Parry (India) Limited is a top sugar producer in India, also involved in Bio-Pesticides and Nutraceuticals. With efficient sugar plants and focus on quality, it is a leading producer of international quality sugar.

Who are the competitors of E.I.D. Parry (I)?

E.I.D. Parry (I) major competitors are Balrampur Chini Mill, Triveni Engg. & Inds, Shree Renuka Sugar, Piccadily Agro Inds, Banna Amman Sugars, Dalmia Bharat Sugar, Bajaj Hindusthan Sug.
Market Cap of E.I.D. Parry (I) is ₹14,815 Crs.
While the median market cap of its peers are ₹5,566 Crs.

Is E.I.D. Parry (I) financially stable compared to its competitors?

E.I.D. Parry (I) seems to be less financially stable compared to its competitors.
Altman Z score of E.I.D. Parry (I) is 3.05 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Strong fundamentals With FII/DII buying And Retail selling

Fundamentally strong companies which are in favour with 'smart money' and going out of favour with retail.

Run Query

Superstar Favourites

Companies where superstar investors like Rakesh Jhunjhunwala, Asish Kacholia have invested

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Sep Dec
Investor Presentation	Feb	Mar Jun Sep Dec	Mar	Mar May Sep			Sep Dec					Sep		Jun Sep	Jun Sep
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun	Dec
Conference Call SummaryCon Call Summary Powered by Gemini